Marker Therapeutics Inc (MRKR)

[Rkmatters]

If GALE fails, of course, there could possibly see a short term stock hit to all dendritic cell vaccines. But they have this thing called "efficacy", and I'm sure that will mean something here. But, that said, I'm actually expecting even GALE's older technology is holding off disease progression and will see success. I own shares on them too, though I just hold more of TPIV. I don't think GALE sold their revenue businesses to concentrate on the oncology market just so they could fail. Odds are is that both will see success. GALE's successful entry into the billion dollar BC market will make TPIV a buy out candidate in a heartbeat.